Jazz Pharmaceuticals plc’s filing revealed that its Officer MARY ELIZABETH HENDERSON acquired Company’s shares for reported $0.38 million on Dec 09 ’25. In the deal valued at $169.51 per share,2,238 shares were bought.
Then, Carr Patricia sold 4,660 shares, generating $797,783 in total proceeds. Upon selling the shares at $171.20, the SVP, Chief Accounting Officer now owns 7,012 shares.
Before that, PATRICIA CARR bought 4,660 shares. Jazz Pharmaceuticals plc shares valued at $797,783 were divested by the Officer at a price of $171.20 per share.
UBS downgraded its Jazz Pharmaceuticals plc [JAZZ] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. UBS also remained covering JAZZ and has increased its forecast on March 07, 2025 with a “Buy” recommendation from previously “Neutral” rating. Cantor Fitzgerald revised its rating on February 26, 2025. It rated JAZZ as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -3.95% to $162.26. Over the last five days, the stock has lost -2.67%. Jazz Pharmaceuticals plc shares have risen nearly 31.77% since the year began. Nevertheless, the stocks have risen 31.76% over the past one year. While a 52-week high of $182.99 was reached on 11/18/25, a 52-week low of $95.49 was recorded on 04/09/25.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 159.38, which if violated will result in even more drops to 156.49. On the upside, there is a resistance level at 167.60. A further resistance level may holdings at 172.93.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2025-11-14, growing by 0.15 million shares to a total of 4.84 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 4.69 million shares. There was a rise of 3.1%, which implies that there is a positive sentiment for the stock.
